These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10098829)

  • 1. Human choriocarcinoma-derived JEG-3 cells transfected with murine MHC class II Aq expression vectors present antigen to Aq-restricted murine T-cell hybridoma.
    Arvola M; Gustafsson E; Brunsberg U; Mattsson R
    J Reprod Immunol; 1999 Jan; 42(1):17-30. PubMed ID: 10098829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
    Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP
    Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
    Murphy SP; Tomasi TB
    Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of detectable major histocompatibility complex class II a beta-chain messenger ribonucleic acid in placentas of interferon-gamma- and 5-azacytidine-treated mice.
    Gustafsson E; Arvola M; Brunsberg U; Mattsson A; Mattsson R
    Biol Reprod; 1997 Oct; 57(4):715-22. PubMed ID: 9314571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of class II major histocompatibility complex antigens in murine placenta by 5-azacytidine and interferon-gamma involves different cell populations.
    Athanassakis-Vassiliadis I; Thanos D; Papamatheakis J
    Eur J Immunol; 1989 Dec; 19(12):2341-8. PubMed ID: 2481591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant negative suppression of major histocompatibility complex genes occurs in trophoblasts.
    Coady MA; Mandapati D; Arunachalam B; Jensen K; Maher SE; Bothwell AL; Hammond GL
    Transplantation; 1999 Jun; 67(11):1461-7. PubMed ID: 10385086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines.
    Weenink S; Averdunk H; Boston T; Boswarva V; Guery JC; Adorini L; Mellins E; McCluskey J; Gautam AM
    Int Immunol; 1997 Jun; 9(6):889-96. PubMed ID: 9199972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane Ia expression and antigen-presenting accessory cell function of L cells transfected with class II major histocompatibility complex genes.
    Norcross MA; Bentley DM; Margulies DH; Germain RN
    J Exp Med; 1984 Nov; 160(5):1316-37. PubMed ID: 6436430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of class II MHC antigen expression on the murine placenta by 5-azacytidine correlates with fetal abortion.
    Athanassakis-Vassiliadis I; Galanopoulos VK; Grigoriou M; Papamatheakis J
    Cell Immunol; 1990 Jul; 128(2):438-49. PubMed ID: 1694110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.
    Holling TM; Schooten E; van Den Elsen PJ
    Hum Immunol; 2004 Apr; 65(4):282-90. PubMed ID: 15120183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction.
    Kingston AE; Bergsteinsdottir K; Jessen KR; Van der Meide PH; Colston MJ; Mirsky R
    Eur J Immunol; 1989 Jan; 19(1):177-83. PubMed ID: 2493382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-mediated transfer of major histocompatibility class II I-Ab and I-Abm12 genes into B lymphoma cells: molecular and functional analysis of introduced antigens.
    Ben-Nun A; Choi E; McIntyre KR; Leeman SA; McKean DJ; Seidman JG; Glimcher LH
    J Immunol; 1985 Aug; 135(2):1456-64. PubMed ID: 3925010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune function of MHC class II molecules mutated in the putative superdimer interface.
    Hayball JD; Lake RA
    Mol Cell Biochem; 2005 May; 273(1-2):1-9. PubMed ID: 16013435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between invariant chain expression level and capability to present antigen to MHC class II-restricted T cells.
    Bertolino P; Forquet F; Pont S; Koch N; Gerlier D; Rabourdin-Combe C
    Int Immunol; 1991 May; 3(5):435-43. PubMed ID: 1655000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide inhibits INFgamma-induced increases in CIITA mRNA abundance and activation of CIITA dependent genes--class II MHC, Ii and H-2M. Class II TransActivator.
    Kielar ML; Sicher SC; Penfield JG; Jeyarajah DR; Lu CY
    Inflammation; 2000 Oct; 24(5):431-45. PubMed ID: 10921507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer immunotherapy by antisense suppression of Ii protein in MHC-class-II-positive tumor cells.
    Qiu G; Goodchild J; Humphreys RE; Xu M
    Cancer Immunol Immunother; 1999 Dec; 48(9):499-506. PubMed ID: 10602887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly efficient peptide binding and T cell activation by MHC class II molecules of CIITA-transfected cells.
    Martinez-Soria E; Siegrist CA; Mach B
    Int Immunol; 1996 Apr; 8(4):543-9. PubMed ID: 8671641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.